Original language | English (US) |
---|---|
Pages (from-to) | 920-923 |
Number of pages | 4 |
Journal | Chest |
Volume | 159 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2021 |
Keywords
- catheter
- effusion
- guideline
- malignant
- pleural
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Critical Care and Intensive Care Medicine
- Cardiology and Cardiovascular Medicine
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Chest, Vol. 159, No. 3, 03.2021, p. 920-923.
Research output: Contribution to journal › Editorial › peer-review
}
TY - JOUR
T1 - Key Highlights From the American Association for Bronchology and Interventional Pulmonology Evidence-Informed Guidelines and Expert Panel Report for the Management of Indwelling Pleural Catheters
AU - Miller, CDR Russell J.
AU - Chrissian, Ara A.
AU - Lee, Y. C.Gary
AU - Rahman, Najib M.
AU - Wahidi, Momen M.
AU - Tremblay, Alain
AU - Hsia, David W.
AU - Almeida, Francisco A.
AU - Shojaee, Samira
AU - Mudambi, Lakshmi
AU - Belanger, Adam R.
AU - Bedi, Harmeet
AU - Gesthalter, Yaron B.
AU - Gaynor, Margaret
AU - MacKenney, Karen L.
AU - Lewis, Sandra Zelman
AU - Casal, Roberto F.
N1 - Funding Information: FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: N. M. R. has received personal fees for consultancy work and an unrestricted educational grant from Rocket Medical and was the lead investigator of the MIST-2 trial, funded by unrestricted educational grant from Roche UK. Y. C. G. L was the lead investigator of AMPLE-1, -2 and currently -3. Rocket Medical provided free drainage equipment for participants in these multicenter randomized trials. He also served on the advisory board of CareFusion/BD (manufacturer of PleurX catheter) and has received an unrestricted educational grant from Rocket Medical UK for support of AMPLE-2. Additionally, he was a co-Investigator of the MIST-2 trial, funded by an unrestricted educational grant from Roche UK. A. T. was a consultant for, and receipt of royalties for intellectual property from BD Inc. (manufacturer of PleurX catheter). None declared (R. J. M., A. A. C., M. M. W., D. W. H., F. A. A., S. S., L. M., A. R. G., H. B., Y. B. G., M. G., K. L. M., R. F. C., S. Z. L.). FUNDING/SUPPORT: These guidelines were commissioned and funded solely by the American Association for Bronchology and Interventional Pulmonology. Funding Information: FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: N. M. R. has received personal fees for consultancy work and an unrestricted educational grant from Rocket Medical and was the lead investigator of the MIST-2 trial, funded by unrestricted educational grant from Roche UK. Y. C. G. L was the lead investigator of AMPLE-1, -2 and currently -3. Rocket Medical provided free drainage equipment for participants in these multicenter randomized trials. He also served on the advisory board of CareFusion/BD (manufacturer of PleurX catheter) and has received an unrestricted educational grant from Rocket Medical UK for support of AMPLE-2. Additionally, he was a co-Investigator of the MIST-2 trial, funded by an unrestricted educational grant from Roche UK. A. T. was a consultant for, and receipt of royalties for intellectual property from BD Inc. (manufacturer of PleurX catheter). None declared (R. J. M., A. A. C., M. M. W., D. W. H., F. A. A., S. S., L. M., A. R. G., H. B., Y. B. G., M. G., K. L. M., R. F. C., S. Z. L.).
PY - 2021/3
Y1 - 2021/3
KW - catheter
KW - effusion
KW - guideline
KW - malignant
KW - pleural
UR - http://www.scopus.com/inward/record.url?scp=85101197000&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101197000&partnerID=8YFLogxK
U2 - 10.1016/j.chest.2020.09.282
DO - 10.1016/j.chest.2020.09.282
M3 - Editorial
C2 - 33152319
AN - SCOPUS:85101197000
SN - 0012-3692
VL - 159
SP - 920
EP - 923
JO - Chest
JF - Chest
IS - 3
ER -